[ Price : $8.95]
FDAs Nonprescription Drugs Advisory Committee plans a 12/14 meeting to review re-formulated over-the-counter oral nasal decongesta...[ Price : $8.95]
Former FDA drug marketing regulator Margaret Peg ORourke joins the French drug industry consulting firm of Cegedim Dendrite.[ Price : $8.95]
CDER says Indevus Pharmaceuticals plans on re-introducing Valstar (valrubicin) by early 2008, following its removal from the marke...[ Price : $8.95]
FDA approves a Novartis NDA for Voltaren Gel, indicated for topical use in treating osteoarthritis pain.[ Price : $8.95]
AdvaMed urges the Supreme Court to support FDAs regulatory authority over medical devices and not allow a state liability suit to ...[ Price : $8.95]
FDA grants a Sequella orphan drug status request for SQ109, an investigational drug for treating tuberculosis.[ Price : $8.95]
FDA approves a Genzyme Corp. sNDA for Renvela (sevelamer carbonate), indicated for controlling serum phosphorus in patients with c...[ Price : $8.95]
FDA says Theravances once-daily injectable antibiotic telavancin is approvable with conditions.